This public procurement contract involves the ongoing supply of pharmaceutical products containing the active ingredients nivolumab and relatlimab. The contract is valued at approximately 129.9 million euros and is intended for the health sector. The buyer is the Faculty Hospital in Olomouc, Czech R
Contract awarded. Originally published 11 months ago.
This public procurement contract involves the ongoing supply of medicinal products and dietary supplements specifically for joint health. The products must meet the requirements set by the State Institute for Drug Control (SÚKL). The total value of the contract is approximately 4,754,799.60 CZK. The
This procurement opportunity involves the establishment of a Dynamic Purchasing System (DPS) for the supply of pharmaceutical products primarily for the Pharmacy of the Faculty Hospital in Olomouc. The aim is to have a wide range of suppliers who will be invited to submit bids for individual public
This public procurement contract involves the ongoing supply of medicinal products and dietary supplements specifically for joint health. The products must meet the requirements set by the State Institute for Drug Control (SÚKL). The total value of the contract is approximately 5,667,582 CZK. Suppli
This public procurement contract involves the ongoing supply of clips for closing large defects in the gastrointestinal tract. Suppliers are required to meet the specifications and minimum technical conditions outlined in the tender documentation. Additionally, the contract includes training for the
Supply non-clinical consumables including forms, labels, and packaging for pathology and primary care services.
Procurement of RSV immunisation vaccine products for adult populations, scheduled for 2028.
Procurement for meningococcal ACWY vaccine supply in 2027 from qualified manufacturers or distributors.
Procurement opportunity for MMR vaccine supply with anticipated delivery timeline of 2027.
